-
公开(公告)号:EP2086938A1
公开(公告)日:2009-08-12
申请号:EP07862645.4
申请日:2007-12-07
申请人: NOVARTIS AG
IPC分类号: C07D213/75 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/12 , C07D413/12 , C07D417/06 , A61K31/44 , A61P35/00
CPC分类号: C07D405/12 , C07D213/75 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D413/12 , C07D417/06
摘要: The present disclosure relates to XIAP inhibitor compound of the formula I: [Chemical formula should be inserted here as it appears on Abstract in paper form] Formula I
摘要翻译: 本公开内容涉及式I的XIAP抑制剂化合物:[化学式在此以摘要呈现在纸上时插入此处]式I
-
公开(公告)号:EP2086938B1
公开(公告)日:2012-01-25
申请号:EP07862645.4
申请日:2007-12-07
申请人: Novartis AG
IPC分类号: C07D213/75 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/12 , C07D413/12 , C07D417/06 , A61K31/44 , A61P35/00
CPC分类号: C07D405/12 , C07D213/75 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D413/12 , C07D417/06
摘要: The present disclosure relates to XIAP inhibitor compound of the formula I: [Chemical formula should be inserted here as it appears on Abstract in paper form] Formula I
-